Bacteriocin-based solutions for diverse industries

Publication ID: 24-11857606_0002_PTD

Published: October 28, 2025

Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Bacteriocin-based solutions for diverse industries,” Published Technical Disclosure No. 24-11857606_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857606_0002_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,606.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of therapeutic bacteriocins to develop novel applications and use cases in various industries, including agriculture, food preservation, bioremediation, biofilm control, and cosmetics.

Background and Problem Solved

The original patent disclosed therapeutic bacteriocins for reducing microbial growth. However, the potential of bacteriocins extends beyond medical applications. The present inventive concept addresses the limitation of the original patent by exploring new industries where bacteriocin-based solutions can provide significant value.

Detailed Description of the Inventive Concept

The inventive concept comprises bacteriocin-based compositions tailored to specific industries. For instance, in agriculture, the bacteriocin targets and kills specific pest species, reducing crop damage and increasing yield. In food preservation, the bacteriocin-based antimicrobial composition prevents spoilage and extends shelf life. Similarly, in bioremediation, the bacteriocin breaks down environmental pollutants, restoring ecological balance. In biofilm control, the bacteriocin prevents biofilm formation, reducing the risk of infection. Lastly, in cosmetics, the bacteriocin targets and reduces acne-causing bacteria, promoting healthy skin.

Novelty and Inventive Step

The new claims introduce novel applications and use cases of bacteriocin-based solutions, which are not obvious from the original patent. The inventive step lies in the adaptation of the core technology to address specific challenges in diverse industries, resulting in innovative solutions with significant commercial potential.

Alternative Embodiments and Variations

Alternative embodiments may include varying the bacteriocin composition, modifying the delivery mechanism, or combining bacteriocins with other agents to enhance their efficacy. Variations may also involve targeting different species or strains within an industry or exploring additional industries where bacteriocin-based solutions can provide value.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across various industries, including agriculture, food preservation, bioremediation, biofilm control, and cosmetics. The target market includes companies, organizations, and governments seeking innovative solutions to address specific challenges in these industries.

CPC Classifications

Section	Class	Group
A	A61	A61K38/43
A	A01	A01N63/10
A	A01	A01N63/50
C	C07	C07K14/21
C	C07	C07K14/26
C	C12	C12N9/2462

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Biotechnology and microbial engineering, focusing on bacteriocin design, antimicrobial compositions, and targeted microbial control across pharmaceutical, agricultural, and industrial applications

Person of Ordinary Skill (PHOSITA) Profile

A skilled researcher with advanced degrees in microbiology, biochemistry, or biotechnology, possessing expertise in protein engineering, microbial interactions, and interdisciplinary applications of antimicrobial technologies

Obviousness Rationale

A PHOSITA would recognize that the core bacteriocin technology from US 11857606 provides a versatile platform for targeted microbial control that can be readily adapted across multiple industries. The fundamental mechanism of receptor-mediated translocation and specific targeting makes the bacteriocin inherently adaptable to diverse applications. Given the known challenges in pest control, food preservation, and biofilm management, a skilled practitioner would naturally explore extending the bacteriocin's utility beyond its original therapeutic context.

Obvious Combinations & Variations

Source Patent Element

Bacteriocin with specific receptor-mediated translocation domain targeting bacterial species

PTD Variation

Agricultural pest control application targeting specific crop-damaging microorganisms

Obviousness Reasoning

Predictable extension of known bacteriocin targeting mechanism to agricultural pest management, representing a straightforward application of existing technological principles

Source Patent Element

Antimicrobial composition capable of killing specific bacterial strains

PTD Variation

Food preservation method preventing microbial spoilage through targeted bacteriocin application

Obviousness Reasoning

Known technique of applying antimicrobial technologies to extend food shelf life, utilizing the bacteriocin's inherent species-specific targeting capabilities

Source Patent Element

Bacteriocin with modular domain structure enabling precise microbial interaction

PTD Variation

Bioremediation system breaking down environmental pollutants through targeted microbial control

Obviousness Reasoning

Logical engineering adaptation applying the bacteriocin's inherent molecular targeting to environmental cleanup challenges, representing a finite and predictable solution

Source Patent Element

Receptor-mediated translocation mechanism for bacterial interaction

PTD Variation

Biofilm prevention method using bacteriocin to disrupt bacterial surface colonization

Obviousness Reasoning

Obvious application of bacteriocin's fundamental mechanism to prevent bacterial aggregation, representing a standard engineering approach to expanding technological utility

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857606, a Person Having Ordinary Skill In The Art would find the disclosed bacteriocin variations in the instant publication to be obvious extensions of the prior art, representing predictable applications of known antimicrobial technologies across diverse industrial contexts. The modular nature of the bacteriocin's design inherently suggests multiple potential implementations, rendering the claimed variations prima facie obvious under 35 U.S.C. § 103.

Original Patent Information

Patent Number	US 11,857,606
Title	Therapeutic bacteriocins
Assignee(s)	BACTOCLEAR HOLDINGS PTE. LTD.